FINANCIALS

TGTX Tg Therapeutics Inc 1001316

Income Statement
Revenue	tgtx20241231_10k	329,004,000
Net Income	tgtx20241231_10k	23,383,000
Profit Margin		7.11%

Balance Sheet
Current Assets	566,359,000
Assets	577,690,000
Current Liabilities	90,679,000
Liabilities	355,326,000
Equity	222,364,000
Shares Out	154,823,000

Cash Flow Statement
Operating Cash Flow	-40,517,000
Investing Cash Flow	-1,036,000

Market Analysis
Market Cap	3,954,182,115
Price	42.17
BVPS	1.44
PB	29.26
EPS	0.60
PE	42.51
PS	3.00
FCF	-41,553,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view TGTX documents filed with the SEC.

TGTX Filings Clear

View A List of Tickers